Document is current
Any future updates will be listed below
-
Authors
Kato, Yasuhiro https://orcid.org/0000-0001-8585-1995
Yamamoto, Gou
Watanabe, Yasutaka
Yamane, Yuki
Mizutani, Hideaki
Kurimoto, Futoshi
Seike, Masahiro
Gemma, Akihiko
Akagi, Kiwamu
Sakai, Hiroshi
- License Information
-
More Information
Article History
Received: 4 January 2021
Accepted: 20 February 2021
First Online: 3 March 2021
Declarations
:
: MS, AG, received consultant fee from Merck Biopharma Co. Ltd, Novartis Pharm K.K., and Pfizer Inc. All other authors have no conflicts of interest.
: All procedures were in accordance with those in the Declaration of Helsinki and approved by the Institutional Review Board of the Saitama Cancer Center (1011).
: Informed consent was obtained from all participants in this study.
